Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 2-5 (IGHV2-5) encodes the variable (V) region of the immunoglobulin heavy chain, a critical part of the antigen-binding site formed in B cell-derived antibodies. The IGHV2-5 gene is one member of the IGHV multigene family located within the immunoglobulin heavy-chain (IGH) locus, which undergoes recombination with diversity (D) and joining (J) segments during B cell development to generate antibody diversity. The V region, comprising three complementarity-determining regions (CDRs) and four framework regions, is responsible for specific antigen recognition and binding, shaping the adaptive immune response. IGHV2-5 features multiple allelic variants, contributing to the diversity of the antibody repertoire in humans; sequence polymorphisms, particularly in CDR1 and CDR2, affect antigen affinity and specificity. IGHV2-5 is not a therapeutic target (like receptor or enzyme); instead, it is a gene segment providing building blocks for antibody molecules. No drugs specifically target IGHV2-5, nor is it a biomarker for disease or drug response. Its clinical relevance is indirect—through its contribution to normal and abnormal antibody responses.
Not applicable (IGHV2-5 is not directly targeted by drugs; its role is inherent to the antigen-binding diversity in antibodies.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 2-5 (IGHV2-5).